Concourse Financial Group Securities, Inc. Immucell Corp Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
29 transactions
Others Institutions Holding ICCC
# of Institutions
25Shares Held
1.29MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA309KShares$1.86 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny160KShares$964,7330.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$795,9660.0% of portfolio
-
Morgan Stanley New York, NY105KShares$632,6430.0% of portfolio
-
Bleichroeder LP New York, NY102KShares$612,6110.22% of portfolio
About IMMUCELL CORP
- Ticker ICCC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,746,860
- Market Cap $46.7M
- Description
- ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...